search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Front End | News


the transition to environments that offer flexibility in computing, storage, and networking options to best meet business needs, while paying only for what is used. The eBook is packed with information on strategies, technologies and products.


Actively engaged in industry standards boards, Molex provides readers with the expertise for data centre management with repeatable, scalable, high-quality solutions. In addition, the eBook offers some of Molex’s latest innovative products,


available from Mouser, like Molex’s EXTreme Ten60 hybrid power-and-signal connectors, providing up to 260A per linear inch, fast response times, and easy configuration for use in a variety of data communication and telecommunication


equipment, as well as consumer electronics.


To read the new eBook, visit https://resources.mouser.com/ manufacturer-ebooks/the-power-of- innovation-and-data


Complying with life science sterilization control mandates T


he traceability of pharmaceutical manufacturing processes is critical to navigating the complexity of government regulations that impact the design, development, production and distribution of medications. The recent introduction of the EudraLex Volume 4 Annex 1 guidance regarding the manufacturing of sterile medicinal products is an example of good manufacturing practices (GMPs) that help ensure quality and safety. But the challenge comes with documenting the process, as Roberto Zerbi, global life sciences business development manager at industrial technology manufacturer Watlow, explains: The EudraLex Volume 4 Annex 1 guidance, which comes into effect in August 2023, illustrates how new regulations are introduced to grow trust in the life sciences business.


Sterilizers play a key role in producing injectable medicines like vaccines. Life science firms and the machine builders that support them must find the most efficient way to meet the data integrity


use of duplex/double probes connected to independent control and monitoring systems).”


When dealing with the challenges of heat and steam sterilization for monitoring and controlling activities, life sciences stakeholders and the OEMs supplying them with equipment are faced with multiple options for meeting the regulatory compliance mandate. But they must always properly balance the trade-off between efficiency, cost and time-to-market.


principles applied to the records of each heat sterilization cycle.


Point 8.50 of the EudraLex Volume 4 Annex 1 states: “Each heat sterilization cycle should be recorded electronically or by hardcopy, using equipment with suitable


accuracy and precision. The system should have safeguards and/or redundancy in its control and monitoring instrumentation to detect a cycle not conforming to the validated cycle parameter requirements and abort or fail this cycle (e.g., by the


The new Annex 1 changes the status quo for OEMs and potentially introduces more machine building cost, time and risk. OEMs must qualify any new device added to their equipment and minimise downtime risks, as well as ensuring staff are trained, expand their maintenance capabilities and manage delays in time-to-market due to extended testing procedures.


To read the full article please visit: https://cieonline.co.uk/complying-with-life- science-sterilization-control-mandates/


https://www.watlow.com


UK connector revenues are up 6% year-on-year, but down 6% on Q1 2023


I


n its half-year report for 2023, ITSA members remain optimistic, despite a tough quarter for the order-book, with sharp declines in the Communications, Data-Processing and Broadcast markets.


Other Key Stats:


 Orders have dropped away sharply against 2022, but are up over Q1 2023.


 Book to Bill for the quarter was just positive at 1:02.


 Distribution down 12% over Q1, but is still up 7% year-on-year.


 Some key markets showed more encouraging signs with Medical +12%, Mil/ Aero +9%, Mass Transport +9% and Test & Measurement +4% over Q1.


www.cieonline.co.uk


 Declines of -20% to -40% in Communications, Data-Processing & Broadcast over Q1.


Despite an ever changing and volatile market situation, ITSA members remain resilient, projecting an optimistic 4-6% growth for the year-end.


Download a full copy of the ITSA Report at: https://itsa.org.uk/wp-content/ uploads/2023/07/ITSA-Report-Half- Year-2023.pdf


The Interconnect Technology Suppliers Association (ITSA) is the only dedicated trade-industry body for interconnect technology companies operating in the UK.


https://itsa.org.uk/ Components in Electronics July/August 2023 9


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66